Matches in Wikidata for { <http://www.wikidata.org/entity/Q98307135> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q98307135 description "2020 թվականի օգոստոսի 11-ին հրատարակված գիտական հոդված" @default.
- Q98307135 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98307135 description "scientific article published on 11 August 2020" @default.
- Q98307135 description "wetenschappelijk artikel" @default.
- Q98307135 description "наукова стаття, опублікована 11 серпня 2020" @default.
- Q98307135 name "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 name "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 type Item @default.
- Q98307135 label "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 label "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 prefLabel "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 prefLabel "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 P1433 Q98307135-F3C747F4-6CB2-4312-BFF0-39E2912067A1 @default.
- Q98307135 P1476 Q98307135-99B5364A-D77F-45E8-B361-74E5EB9318D6 @default.
- Q98307135 P2093 Q98307135-0062E694-F0B4-4E8C-9C1E-A6E805A311E4 @default.
- Q98307135 P2093 Q98307135-1337083A-1F3E-4C31-990F-AA30713F8A06 @default.
- Q98307135 P2093 Q98307135-2A223592-3A10-4A42-9880-9DF46F5AF8A8 @default.
- Q98307135 P2093 Q98307135-3E706CFB-EF07-4689-AB47-F8B4C6806EC6 @default.
- Q98307135 P2093 Q98307135-604429C0-CF14-496E-9B7F-5AD2F65EED6B @default.
- Q98307135 P2093 Q98307135-983066D0-C9D3-4BFF-8540-BD5C9A2C980E @default.
- Q98307135 P2093 Q98307135-9CDDAE0B-76BD-4663-B3BA-9C672DAE5827 @default.
- Q98307135 P2093 Q98307135-9E2CEE18-EDBE-47C5-9DFD-CA8043ADDDD6 @default.
- Q98307135 P2093 Q98307135-A8878C8F-B52A-4887-82FF-E9E1EE363F19 @default.
- Q98307135 P2093 Q98307135-AA99D809-5490-4D99-BB7B-B733CCD700AC @default.
- Q98307135 P2093 Q98307135-DC6FB4CD-B02D-420D-8C57-A1E4E76AD3A7 @default.
- Q98307135 P31 Q98307135-4B78B0FD-05B5-4DC5-BF2A-688A2C3154FA @default.
- Q98307135 P356 Q98307135-249FCC5C-179A-45C8-9C40-91CDF911D1DF @default.
- Q98307135 P50 Q98307135-73971F14-082D-4AB2-A4C7-676D388DEB1A @default.
- Q98307135 P50 Q98307135-CB1CB2D5-5FE1-44B0-9ECC-A313A2B31153 @default.
- Q98307135 P50 Q98307135-F0C131F1-6824-4D07-9C63-14E8FF017A04 @default.
- Q98307135 P577 Q98307135-F2150EAD-9AA8-411E-90CE-921D4885B776 @default.
- Q98307135 P698 Q98307135-2D6030CC-48A1-4A96-83F2-AA090795BB37 @default.
- Q98307135 P921 Q98307135-54E3EB40-7B27-4FF1-AF92-F71C5ED3D00A @default.
- Q98307135 P921 Q98307135-D8B4546C-750E-4126-89EA-F7D65E579639 @default.
- Q98307135 P356 ART.41481 @default.
- Q98307135 P698 32779863 @default.
- Q98307135 P1433 Q4797636 @default.
- Q98307135 P1476 "Open Label, Phase II Study with Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease" @default.
- Q98307135 P2093 "Bilade Cherqaoui" @default.
- Q98307135 P2093 "Caroline Galeotti" @default.
- Q98307135 P2093 "Corinne Guitton" @default.
- Q98307135 P2093 "Céline Piedvache" @default.
- Q98307135 P2093 "Helene Agostini" @default.
- Q98307135 P2093 "Isabelle Marie" @default.
- Q98307135 P2093 "Karine Brochard" @default.
- Q98307135 P2093 "Moshe Arditi" @default.
- Q98307135 P2093 "Nadja Boukhedouni" @default.
- Q98307135 P2093 "Stéphanie Tellier" @default.
- Q98307135 P2093 "Virginie Lambert" @default.
- Q98307135 P31 Q13442814 @default.
- Q98307135 P356 "10.1002/ART.41481" @default.
- Q98307135 P50 Q45340353 @default.
- Q98307135 P50 Q90199019 @default.
- Q98307135 P50 Q96302063 @default.
- Q98307135 P577 "2020-08-11T00:00:00Z" @default.
- Q98307135 P698 "32779863" @default.
- Q98307135 P921 Q265936 @default.
- Q98307135 P921 Q415411 @default.